Mass Spec Technology Drives Innovation Across the Biopharma Workflow

Article   Sep 23, 2016

 
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
 
 
 

RELATED ARTICLES

Developments in Continuous Cell Culture

Article

Continuous cell culture is part of a trend in bioprocessing towards highly productive, streamlined, and interconnected unit operations. While continuous processing has a long history in various industries, regulatory concerns have stalled widespread adoption of continuous bioprocessing. That is beginning to change as the industry acclimates to regulators’ desire for risk- and science-based production decisions.

READ MORE

The Viral Genome: Moving Beyond Reading Code – Why Not Rewrite It?

Article

Researchers have discovered how to read, decode, and manipulate previously ‘hidden’ viral code. This could open up new opportunities in drug delivery and gene therapy.

READ MORE

How We Tackle Antibiotic Resistance Now

Article

The fight against antibiotic resistance is real and is something we all have a responsibility in tackling. In fact, antibiotic resistance kills an estimated 700,000 people each year and has fuelled the re-emergence of illnesses that had become a rarity in many parts of the world.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE